Project Grant R43GM157773
Award Date
5/1/25
Completion Date
4/30/26
Dollars Obligated
$280K
Federal Agency
National Institute of General Medical Sciences
Awardee
Palladias LLC (N1VRMZTBH195)
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Los Alamos, NM 87544, USA
Similar Awards
This $146,816 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of novel peptide catalysts for stereo- and site-selective carbon-carbon bond formation reactions. The project leverages automated fast-flow peptide synthesis and machine learning to access a broad chemical space of mid-length peptide catalysts containing non-natural amino acids. One research direction focuses on...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), will support research at Occidental College on palladium-catalyzed decarboxylative coupling reactions. The primary goals are to expand the scope of these reactions to synthesize biologically relevant molecular structures, develop a palladium-catalyzed cyclopropanation process, and elucidate the mechanistic basis for...
This $360,100 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports research to develop new pharmaceutical synthetic methods through supramolecular catalysis. The Principal Investigator at the University of California, Berkeley will leverage pioneering work in supramolecular hosts and transition metal catalysis to enable transformations relevant to drug discovery, including...
This federal Project Grant award of $357,056 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research efforts at Wayne State University to adapt heterogeneous materials and macromolecules for use in high-throughput organic synthesis. The key products and services to be delivered through this 5-year award include: Developing colloidal suspensions of insoluble inorganic reagents to enable their use in...
The federal Project Grant award R35GM156435 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The $259,966 grant, awarded on April 21, 2025, supports the development of new synthetic strategies to functionalize pyridine and diazine heterocycles, which are key structural components in many FDA-approved drugs. The research aims to enable medicinal chemists to directly and selectively install a range...
This $420,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to expand the scope of methodologies for chemical probe development toward underexplored biological targets and accelerate drug discovery. The research program has two primary objectives: 1) Improving the throughput of medicinal chemistry through an advanced high-throughput medicinal chemistry (HTMC) platform based on...
This $752,456 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development and application of innovative computational technologies for the design of small-molecule ligands. The key products and services to be delivered over the 5-year project period include: Creating a large database of predicted protein-ligand complexes to improve the accuracy of structure-based machine learning...
This Project Grant award of $371,371.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development and application of reactions to enable molecular rigidification. The award will fund a research program focused on developing reactions to access rigid small and medium-sized strained rings, using sulfone anions as carbene surrogates and new methods to stabilize reactive alkylidene units through...
This Project Grant award, with Federal Grant Award ID F32GM153091, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The $364,324 award supports research by the Massachusetts Institute of Technology (MIT) to elucidate the steric and electronic parameters of phosphorus-based catalysts necessary for enantioselective tandem amidation and amide functionalization reactions. The goal is to develop a...
This $1,542,569 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of new copper-catalyzed reactions for the stereoselective synthesis of chiral amine and ether derivatives, including saturated heterocycles. The objectives include exploring reactions that propagate chirality initiated by enantioselective copper-catalysis, developing a new synthesis of enantioenriched oxygen...